Evidence map›Paper›PMID 25011656›Full record

Observational studyCritical care (London, England)2014

Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study.

Michael Zoller, Barbara Maier, Cyrill Hornuss, Christina Neugebauer, Gundula Döbbeler, Dorothea Nagel, Lesca Miriam Holdt, Mathias Bruegel, Thomas Weig, Béatrice Grabein and 4 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Critical care (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01793012 (Drug Monitoring of Antibiotics in Critical Care Patients), which is not on this map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01793012 completednot on this map

Drug Monitoring of Antibiotics in Critical Care Patients

TypeobservationalSponsorLudwig-Maximilians - University of MunichRan2013 to 2015Enrolled186ConditionsARDS, Sepsis
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. [Research on the pharmacokinetics of linezolid in burn patients].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2026
    Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Efficacy and Safety of Continuous vs Intermittent Linezolid Infusion in Critically Ill Patients with Septic Shock.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Linezolid brain penetration in neurointensive care patients.The Journal of antimicrobial chemotherapy · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Hemoadsorption with CytoSorbJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Michael Zoller
Barbara Maier
Cyrill Hornuss
Christina Neugebauer
Gundula Döbbeler
Dorothea Nagel
Lesca Miriam Holdt
Mathias Bruegel
Thomas Weig
Béatrice Grabein
Lorenz Frey
Daniel Teupser
Michael Vogeser
Johannes Zander

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSevere infections in intensive care patients show high morbidity and mortality rates. Linezolid is an antimicrobial drug frequently used in critically ill patients. Recent data indicates that there might be high variability of linezolid serum concentrations in intensive care patients receiving standard doses. This study was aimed to evaluate whether standard dosing of linezolid leads to therapeutic serum concentrations in critically ill patients.

methodsIn this prospective observational study, 30 critically ill adult patients with suspected infections received standard dosing of 600 mg linezolid intravenously twice a day. Over 4 days, multiple serum samples were obtained from each patient, in order to determine the linezolid concentrations by liquid chromatography tandem mass spectrometry.

resultsA high variability of serum linezolid concentrations was observed (range of area under the linezolid concentration time curve over 24 hours (AUC24) 50.1 to 453.9 mg/L, median 143.3 mg*h/L; range of trough concentrations (Cmin) < 0.13 to 14.49 mg/L, median 2.06 mg/L). Furthermore, potentially subtherapeutic linezolid concentrations over 24 hours and at single time points (defined according to the literature as AUC24 < 200 mg*h/L and Cmin < 2 mg/L) were observed for 63% and 50% of the patients, respectively. Finally, potentially toxic levels (defined as AUC24 > 400 mg*h/L and Cmin > 10 mg/L) were observed for 7 of the patients.

conclusionsA high variability of linezolid serum concentrations with a substantial percentage of potentially subtherapeutic levels was observed in intensive care patients. The findings suggest that therapeutic drug monitoring of linezolid might be helpful for adequate dosing of linezolid in critically ill patients.

trial registrationClinicaltrials.gov NCT01793012. Registered 24 January 2013.

Indexed as

AcetamidesAnti-Infective AgentsCritical IllnessIntensive Care UnitsOxazolidinonesAdultAgedAged, 80 and overDose-Response Relationship, DrugFemaleHumansLinezolidMaleMiddle AgedProspective StudiesAcetamidesAnti-Infective AgentsLinezolidOxazolidinones

Identifiers

PMID25011656
PMCPMC4227093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.